• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺维科夫肝癌中的药物代谢:混合功能氧化酶系统的证据及细胞色素P-450还原酶的部分纯化

Drug metabolism in the Novikoff hepatoma: evidence for a mixed function oxidase system and partial purification of cytochrome P-450 reductase.

作者信息

Saine S E, Fang W F, Strobel H W

出版信息

Biochim Biophys Acta. 1978 Oct 12;526(2):345-58. doi: 10.1016/0005-2744(78)90126-2.

DOI:10.1016/0005-2744(78)90126-2
PMID:718941
Abstract

Novikoff kepatoma microsomes catalyze the hydroxylation of benzphetamine and ethylmorphine at rates less than 1% of those of liver microsomes but catalyze the hydroxylation of p-nitroanisole and p-nitrophenetole at rates about 40% of those of liver microsomes. Benzo[a]pyrene hydroxylation is also catalyzed by Novikoff hepatoma microsomes at about 2% of the rate of liver microsomes. Like the hepatic microsomal system the rates of substrate hydroxylation by Novikoff hepatoma microsomes can be increased by pretreatment with phenobarbital/hydrocortisone or beta-naphthoflavone and inhibited by carbon monoxide, SKF-525A, and 7,8-benzoflavone. In addition, NADPH-cytochrome P-450 reductase (NADPH:ferricytochrome oxidoreductase, EC 1.6.2.4) has been partially purified from Novikoff hepatoma ascites cells and some properties are described. The induction and inhibition characteristics of the Novikoff hepatoma microsomal hydroxylation activities and the isolation of a cytochrome P-450 reductase from the hepatoma are consistent with the presence of a functional mixed function oxidase system in the Novikoff hepatoma, analogous to that present in liver endoplasmic reticulum.

摘要

诺维科夫肝癌微粒体催化苄非他明和乙基吗啡的羟基化反应,其速率不到肝微粒体的1%,但催化对硝基苯甲醚和对硝基苯乙醚的羟基化反应,速率约为肝微粒体的40%。诺维科夫肝癌微粒体催化苯并[a]芘羟基化反应的速率约为肝微粒体的2%。与肝微粒体系统一样,诺维科夫肝癌微粒体对底物羟基化的速率可通过苯巴比妥/氢化可的松或β-萘黄酮预处理而增加,并受到一氧化碳、SKF-525A和7,8-苯并黄酮的抑制。此外,已从诺维科夫肝癌腹水细胞中部分纯化出NADPH-细胞色素P-450还原酶(NADPH:铁细胞色素氧化还原酶,EC 1.6.2.4),并描述了其一些特性。诺维科夫肝癌微粒体羟基化活性的诱导和抑制特性以及从肝癌中分离出细胞色素P-450还原酶,与诺维科夫肝癌中存在功能性混合功能氧化酶系统一致,类似于肝内质网中存在的系统。

相似文献

1
Drug metabolism in the Novikoff hepatoma: evidence for a mixed function oxidase system and partial purification of cytochrome P-450 reductase.诺维科夫肝癌中的药物代谢:混合功能氧化酶系统的证据及细胞色素P-450还原酶的部分纯化
Biochim Biophys Acta. 1978 Oct 12;526(2):345-58. doi: 10.1016/0005-2744(78)90126-2.
2
The drug metabolism systems of liver and liver tumors: a comparison of activities and characteristics.肝脏及肝脏肿瘤的药物代谢系统:活性与特征比较
Mol Cell Biochem. 1978 Dec 22;22(2-3):79-91. doi: 10.1007/BF00496236.
3
Role of colonic cytochrome P-450 in large bowel carcinogenesis.结肠细胞色素P-450在大肠癌发生中的作用。
Cancer. 1980 Mar 15;45(5 Suppl):1060-5. doi: 10.1002/1097-0142(19800315)45:5+<1060::aid-cncr2820451305>3.0.co;2-e.
4
Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.食蟹猴肝脏微粒体细胞色素P450的诱导
Drug Metab Dispos. 1995 Jul;23(7):736-48.
5
Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation.纯化的细胞色素P-450和P-448对联苯羟基化和乙氧基试卤灵脱乙基反应的固有特异性。
Drug Metab Dispos. 1975 Jul-Aug;3(4):245-53.
6
Microsomal monooxygenase system in Morris hepatoma: purification and characterization of cytochromes P-450 from Morris hepatoma 5123D of 3-methylcholanthrene-treated rats.莫里斯肝癌中的微粒体单加氧酶系统:来自经3-甲基胆蒽处理大鼠的莫里斯肝癌5123D细胞色素P-450的纯化与特性分析
Arch Biochem Biophys. 1985 Jan;236(1):176-84. doi: 10.1016/0003-9861(85)90617-4.
7
Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity.大鼠结肠中的药物代谢:酶成分的解析及活性表征
Mol Cell Biochem. 1987 May;75(1):51-60. doi: 10.1007/BF00231608.
8
Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.抗乳腺癌抗雌激素药物他莫昔芬的代谢。I. 细胞色素P-450催化的N-去甲基化和4-羟基化作用。
Drug Metab Dispos. 1993 Jul-Aug;21(4):645-56.
9
Differential effects of proteinase K on the components of the liver microsomal cytochrome P-450 mixed function oxidase system.蛋白酶K对肝脏微粒体细胞色素P - 450混合功能氧化酶系统各组分的不同作用。
Drug Metab Dispos. 1991 Nov-Dec;19(6):1016-21.
10
Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.人、兔和大鼠肝微粒体以及纯化形式的细胞色素P-450对甲苯磺丁脲的羟基化作用。
Drug Metab Dispos. 1990 May-Jun;18(3):356-61.

引用本文的文献

1
In vitro modulation of antioxidant enzymes in normal and malignant renal epithelium.正常和恶性肾上皮细胞中抗氧化酶的体外调节
In Vitro Cell Dev Biol. 1987 Aug;23(8):546-58. doi: 10.1007/BF02620972.
2
Studies on lipid peroxidation in normal and tumour tissues. The Novikoff rat liver tumour.正常组织与肿瘤组织中脂质过氧化的研究。诺维科夫大鼠肝癌。
Biochem J. 1986 Apr 15;235(2):507-14. doi: 10.1042/bj2350507.